Comparison between proton pump inhibitor and placebo in improving laryngeal signs of laryngopharyngeal reflux patients ——a Meta analysis

HU Ying,ZHANG Tian-yu,XU Xiao-bing

DOI: https://doi.org/10.3969/j.issn.1671-2420.2013.02.014

2013-01-01

Abstract:Objective To compare the roles of proton pump inhibitor(PPI) and placebo in the improvement of laryngeal signs of patients with laryngopharyngeal reflux(LPR). Methods Published and unpublished articles which compare the therapeutic outcomes of LPR using PPI and placebo in randomized controlled clinical trials were collected. The quality of the searched original studies were assessed and the outcomes which are in line with the requirements were analyzed. Results Seven articles met the inclusion criteria, which contained 417 cases in total. There were 233 cases in the PPI group and 184 cases in the placebo group. The standardized mean differences (SMD) was 0.53 with a 95% confidence interval (-0.44,1.50), P=0.28. The data of PPI vs placebo therapy for 12 weeks were provided in 4 articles. The SMD was 1.12 with a 95% confidence interval (-1.54, 3.78), P= 0.41. Conclusions There was no significant evidence to prove a superior role of PPI compared to the placebo in improving laryngeal signs of LPR patients.